I see your point, but something still seems different. Yes we bred plants and animals, but we did not create them. Yes we did build steam engines before understanding thermodynamics but we still understood what they did (heat, pressure, movement, etc.)
Fun fact: we have no clue how most drugs works. Or, more precisely, we know a few aspects, but are only scratching the surface. We're even still discovering news things about Aspirin, one of the oldest drugs: https://www.nature.com/articles/s41586-025-08626-7
I’ve only skimmed the paper - a long and dense read - but it’s already clear it’ll become a classic. What’s fascinating is that engineering is transforming into a science, trying to understand precisely how its own creations work
This shift is more profound than many realize. Engineering traditionally applied our understanding of the physical world, mathematics, and logic to build predictable things. But now, especially in fields like AI, we’ve built systems so complex we no longer fully understand them. We must now use scientific methods - originally designed to understand nature - to comprehend our own engineered creations. Mindblowing.
Agreed. But just say that. No need to pretend taking responsibility, which is defined as facing consequences when things go bad.
“As CEO, I’m truly sorry to those impacted. But I strongly believe that this change is what is needed now to make sure Dropbox can thrive in the future.”
I completely agree. LLMs are incredibly useful for improving the flow and structure of an argument, not just for non-native speakers, but even for native English speakers.
Making texts more accessible through clear language and well-structured arguments is a valuable service to the reader, and I applaud anyone who leverages LLMs to achieve that. I do the same myself.
I'm a bit puzzled why one would hold a press conference for a trial that hasn't happened yet - especially as this seems to be a phase 1 trial to test safety in humans.
The development of medical interventions typically goes through a number of stages.
The earliest stage is called the pre-clinical phase, where a candidate intervention is tested outside of humans, either in vitro or in animals. The images of the mouse and ferret teeth suggest this has been done.
Phase 1 is when the intervention is first tested in humans, typically in small groups of usually dozens of participants. The aim here is not to evaluate efficacy - phase 1 studies are often too small for that - but to assess tolerability and safety, and to find the optimal dosing with respect to side effects.
If an intervention appears safe in certain doses, it can then be evaluated for initial efficacy and continued safety in a phase 2 trial, which is larger (usually hundreds of participants). Think of it as a kind of pilot trial to see if the intervention has the desired beneficial effects without serious negative side effects, and to identify the dose with the best benefit/risk ratio. About half of the studies get past this stage.
Those that do can enter phase 3, which is the full efficacy and safety assessment of the intervention. Again, about half of the phase 3 trials eventually make it to market. Of course, the intervention first needs to go to the health authorities for regulatory approval before it can be offered on the market.
Fun fact: we have no clue how most drugs works. Or, more precisely, we know a few aspects, but are only scratching the surface. We're even still discovering news things about Aspirin, one of the oldest drugs: https://www.nature.com/articles/s41586-025-08626-7